Search for: "Bristol Myers Squibb" Results 621 - 640 of 866
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Sep 2010, 2:16 pm by Mark Zamora
Image via WikipediaBristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.The company said it took the action on behalf of the Bristol-Myers Squibb/Sanofi-Synthelabo partnership because of a potential variability in levels of the less-soluble form of the active ingredient in Avalide, irbesartan, which could result in slower dissolution.Bristol-Myers said 62… [read post]
28 Sep 2010, 3:14 pm by Kelly
Par Pharmaceutical Companies, Inc. et al (Patent Docs) Baraclude (Entecavir) – US: Patent infringement complaint filed following Paragraph IV certification: Bristol-Myers Squibb Co. v. [read post]
7 Sep 2010, 11:15 pm by By DEALBOOK
Bristol-Myers Squibb said Tuesday it had agreed to acquire ZymoGenetics, the maker of a hepatitis C drug the companies were jointly developing, for $885 million. [read post]
22 Aug 2010, 10:16 pm
Pfizer, GlaxoSmithKline, Merck, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Baxter, SciClone are a few of the drug manufacturers that the United States Department of Justice (DOJ) is investigating for violation of bribery laws and corruption in foreign markets under the Foreign Corrupt Practices Act. [read post]
18 Aug 2010, 12:19 am by Kelly
(IP Whiteboard) Australia: A tale of four amendment requests: Bristol-Myers Squibb Company v. [read post]
13 Aug 2010, 12:46 pm
See Bristol-Myers Squibb Co. v. [read post]
22 Jul 2010, 7:10 am
" The group of drugs under concern include some of the top-selling blood pressure drugs, such as  Cozaar, which is manufactured by Merck, and Avapro, a Bristol-Myers Squibb drug. [read post]
16 Jul 2010, 12:00 pm by Lucas A. Ferrara, Esq.
Bristol-Myers Squibb is committed to ensuring patient safety and is working to resolve this issue quickly and appropriately. [read post]
1 Jul 2010, 1:32 pm by Richard Renner
Grassley letters are available in the continuation of this blog entryBelow are links to the letters sent by Grassley to: Abbott Laboratories Amgen AstraZeneca Pharmaceuticals Boehringer Bristol-Myers Squibb Company Eisai Corporation of America Eli Lilly and Company Forest Laboratories GlaxoSmithKline Hoffman-La Roche Inc. [read post]
30 Jun 2010, 6:35 am by Ashby Jones
Two former Bristol-Myers Squibb Co. executives have reached agreements under which they will avoid criminal prosecution for an alleged scheme to artificially pump up the drug maker's results. [read post]
24 Jun 2010, 5:00 am by Bexis
Bristol-Myers Squibb Co., 181 F.R.D. 365 (N.D. [read post]
21 Jun 2010, 9:57 am
They ask as follows: "(i) Are Article 7(2) of [the repealed and re-enacted but regularly cited] Council Directive 89/104 ... to approximate the laws of the Member States relating to trade marks and the associated case-law, in particular the judgments of the Court of Justice in Cases 102/77 Hoffmann-La Roche v Centrafarm and 1/81 Pfizer v Eurim-Pharm and Joined Cases C-427/93, C-429/93 and C-436/93 Bristol-Myers Squibb and Others v Paranova, to be interpreted as… [read post]
2 Jun 2010, 3:15 am by Scott A. McKeown
Bristol-Myers Squibb Co., 326 F.3d at 1241; see Molins PLC, 48 F.3d at 1182 (“We recognize that [the withheld references] were cited eventually to the PTO and that the examiner . . . passed the reexamination application to issue thereafter. [read post]
13 May 2010, 12:27 pm by Bexis
Bristol-Myers Squibb Co., 2009 WL 5216984 (D.N.J. [read post]
5 May 2010, 5:03 am by Mark Zamora
Several European countries have recalled batches of generic heart drug Plavix made at a factory in India.Plavix, or clopidogrel, is sold as a brand by Sanofi-Aventis and Bristol-Myers Squibb and is the world's second biggest-selling medicine, with worldwide sales of more than $9 billion a year.The medicine is off patent in some European markets.Source here. [read post]
4 May 2010, 7:19 am by Theo Francis
Take Bristol Myers Squibb (BMY), for example. [read post]
4 May 2010, 7:19 am by Theo Francis
Take Bristol Myers Squibb (BMY), for example. [read post]
27 Apr 2010, 5:01 am by Broc Romanek
" Bristol-Myers Squibb Company: "Our Board meets regularly to discuss the strategic direction and the issues and opportunities facing our company in light of trends and developments in the biopharmaceutical industry and general business environment. [read post]